Ehime Bank (TSE:8541) has reported a solid set of Q3 2026 numbers, with revenue of ¥13.2b and net income of ¥2.3b translating into basic EPS of ¥59.04. Over the trailing twelve months, net income reached ¥7.1b and EPS came in at ¥181.02. In recent quarters, the bank has reported revenue between ¥11.4b in Q1 2026 and ¥13.0b in Q4 2025, with quarterly EPS moving between ¥15.12 and ¥59.04 as profitability shifted through the year. Net profit margins were 14% over the last twelve months compared...
As the Asian markets navigate a landscape marked by political shifts and economic recalibrations, investors are keenly observing opportunities that may arise from these evolving conditions. In this context, identifying stocks that are potentially undervalued could offer strategic entry points for those looking to capitalize on discrepancies between market price and intrinsic value.
As we navigate through early 2026, the Asian markets are capturing attention amid a backdrop of mixed global economic signals, with small-cap stocks facing challenges similar to those seen in other regions. Despite the cautious sentiment and varied performance across key indices, this environment can offer opportunities for discerning investors to identify stocks with strong fundamentals and growth potential that may have been overlooked.
ASKA Pharmaceutical HoldingsLtd (TSE:4886) has put up a solid Q3 2026 print, with revenue at ¥19.2 billion and basic EPS of ¥59.09, anchored by net income of ¥1,678 million for the quarter. Over the recent quarters, the company has seen revenue move from ¥17.6 billion in Q3 2025 to ¥19.2 billion in Q3 2026, while basic EPS shifted from ¥54.23 to ¥59.09 as net income went from ¥1,538 million to ¥1,678 million. This sets a clear context for how the latest numbers fit into its recent track...
Kiyo Bank (TSE:8370) has reported solid numbers for Q3 2026, with revenue of ¥30,564 million and basic EPS of ¥99.23. Trailing twelve month EPS stands at ¥335.29 on revenue of ¥95,787 million and net income of ¥21,494 million. Over recent quarters the bank’s revenue has moved from ¥23,840 million in Q4 2025 to ¥22,188 million in Q1 2026 and then ¥17,463 million in Q2 2026, before reaching the latest ¥30,564 million figure. EPS over the same periods shifted from ¥96.61 to ¥69.71, then ¥41.03,...